Can You Take Atorvastatin and Gemfibrozil Together? What You Need to Know About This Drug Interaction
Learn about the documented moderate interaction between atorvastatin and gemfibrozil, how OATP1B1 transporter inhibition affects drug lev...
Taking celecoxib (the generic name for Celebrex) together with warfarin is classified as a major interaction by FDA drug labeling. Concomitant use increases your risk of bleeding complications, including serious and potentially fatal bleeding events that have been documented after the drugs were already on the market. This is especially important if you are elderly. You should not make any medication changes on your own, but you absolutely need to talk with your pharmacist or physician if you are taking both drugs or if you are considering starting either one while already taking the other.
The interaction between celecoxib and warfarin is documented in the FDA labeling for celecoxib (the source we rely on for this information). Here are the facts from that labeling:
This is not a theoretical or predicted interaction—it is one that has been observed in actual patients taking both medications and documented through post-marketing surveillance, meaning it was identified after the drugs were approved and in widespread use.
To make sense of this interaction, it helps to understand what each drug does and why taking them together is risky.
Warfarin is an anticoagulant, commonly known as a blood thinner. It works by reducing your blood's ability to clot. People take warfarin to prevent dangerous blood clots in conditions like atrial fibrillation, after heart valve replacement, or after certain blood clots have already formed. A lower clotting ability is the goal in these patients—it prevents clots from forming where they shouldn't. However, this also means warfarin increases the risk of bleeding if you are injured or if your bleeding system is disrupted.
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs reduce pain, inflammation, and fever by blocking substances in the body that trigger inflammation and pain signals. They are commonly used for arthritis, back pain, menstrual cramps, and other painful conditions.
The FDA labeling for celecoxib does not specify the exact mechanism of how celecoxib and warfarin interact. However, we can explain what is known from general pharmacology: NSAIDs like celecoxib can interfere with platelet function (platelets are blood cells that help form clots) and can also affect how the body processes warfarin. When you take an NSAID while already on a blood thinner, both drug actions work in the same direction—increasing bleeding risk. In addition, NSAIDs can irritate the stomach lining, and that irritation itself increases the risk of internal bleeding, especially in the digestive tract. When a stomach-irritating drug is combined with a blood thinner, the risk multiplies.
The documented post-marketing reports in the source record show that this is not merely a theoretical concern. Real patients have experienced serious and fatal bleeding while taking these two drugs together.
The source record mentions increases in prothrombin time. Prothrombin time (PT) is a blood test that measures how long it takes your blood to clot. When you take warfarin, doctors monitor your PT—or more commonly, a related measure called INR (International Normalized Ratio)—to make sure your dose is safe and effective. If celecoxib causes your PT to increase further, it means your blood's clotting ability has been reduced even more, raising the bleeding risk.
The source record specifically identifies elderly patients as being at higher risk from this interaction, with documented increases in prothrombin time in this age group. Older adults may have other health conditions, take multiple other medications, or have changes in kidney or liver function that affect how drugs are processed. These factors can amplify the interaction risk.
However, this interaction is major for all patients, not just elderly ones. Anyone taking both celecoxib and warfarin should be aware of the elevated bleeding risk, regardless of age. If you have a history of stomach ulcers, kidney disease, liver disease, or bleeding disorders, or if you are taking other medications that affect bleeding or blood clotting, your risk may be even higher—but that assessment requires your pharmacist or physician to review your full medical history.
Consider a 72-year-old patient who has atrial fibrillation and takes warfarin to prevent stroke risk from blood clots. One day, the patient develops knee pain from arthritis and asks his doctor about celecoxib. The combination is identified as a major interaction. The physician might suggest an alternative pain reliever (such as acetaminophen) or a different approach to managing the arthritis pain, and will monitor blood-clotting tests closely if celecoxib is deemed necessary despite the risk. This is a hypothetical scenario to illustrate how the source-documented risk affects clinical decision-making.
A 55-year-old patient has been stable on warfarin for a previous blood clot. Her doctor previously recommended celecoxib for arthritis, and close monitoring was in place. Her PT/INR had remained stable. Now suppose she develops a stomach ulcer (an upper-GI bleed risk factor). The interaction risk becomes more serious because NSAIDs irritate the stomach, and she is already on a blood thinner. Her physician would likely reassess whether continuing celecoxib is safe. Again, this is hypothetical but illustrates how the documented interaction risk must be weighed against individual circumstances.
If you are already taking both celecoxib and warfarin, or if you are considering one of these drugs while already taking the other, here are critical conversations to have:
Do not stop or change either medication without talking to your pharmacist or doctor first. Stopping warfarin suddenly can cause blood clots. But do make sure this conversation happens soon, especially if you haven't discussed the interaction recently.
If you are taking celecoxib, warfarin, or any other medications, use checkdruginteractions.com to review your full medication list for documented interactions. The site draws from FDA labeling and NIH/NLM data to help you identify risks. After you check your medications, confirm all decisions about starting, stopping, or changing any drug with your pharmacist or physician. Your healthcare provider knows your full medical history and can weigh the benefits and risks in your specific situation. Do not delay—especially if you are taking both celecoxib and warfarin, or if you are elderly or have other health conditions that increase bleeding risk.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Learn about the documented moderate interaction between atorvastatin and gemfibrozil, how OATP1B1 transporter inhibition affects drug lev...
Fluoxetine and pimozide should not be used together due to QT interval prolongation risk. Learn what this means and what to discuss with ...
Furosemide is contraindicated with lithium due to reduced renal clearance and high toxicity risk. Learn why and what to discuss with your...